Innovestor
VC Fund
Helsinki, Finland
Innovestor is a nordic venture capital investor and financial services company. For investors, Innovestor offers attractive opportunities to invest in carefully selected growth companies. For growth companies, Innovestor offers funding at competitive terms and valuable insight from a team of experienced professionals and industry experts.Innovestor offices are located in Helsinki, Jyväskylä, Stockholm and Moscow. Innovestor Ltd. is supervised by Finnish Financial Supervisory Authority.
- Total investments:
- 89
- Last investment:
- Lead investor:
- 58%
- Fund size:
- $35M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Innovestor invests in
Stages Innovestor invests in
Countries Innovestor invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $478k–$4.5M
- Pre-Seed
- $204k–$2M
Investment Focus
Industry
- Software 15 (17%)
- Health Care 12 (13%)
- Information Technology 12 (13%)
- Medical 9 (10%)
- Manufacturing 8 (9%)
Stage
- Seed 27 (30%)
- Funding Round 16 (18%)
- Pre-Seed 15 (17%)
- Series A 12 (13%)
- Venture - Series Unknown 6 (7%)
Country
- Finland 56 (63%)
- Sweden 5 (6%)
- Denmark 4 (4%)
- Norway 1 (1%)
- Lithuania 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Hannu Jungman
Partner, Innovestor Ventures
|
Partner, Innovestor Ventures | Total investments: 4 | Find email | |
Janne Juhola
Partner
|
Partner | Total investments: 0 | Find email | |
Myron Seto
Partner
|
Partner | Total investments: 6 | Find email | |
Petri Laine
Managing Partner
|
Managing Partner | Total investments: 4 | Find email | |
Wilhelm Lindholm
Partner and CEO
|
Partner and CEO | Total investments: 5 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Cornea Sense
|
CorneaSense is a medtech startup developing a non-invasive, eye-based sensing device that measures ocular surface hydration to enable early detection and monitoring of conditions such as dry eye disease and systemic health disorders. The technology aims to provide real-time, objective eye biomarkers for improved clinical diagnosis and patient care. | $1.3M / Pre-Seed / Jul 13, 2026 | |
Retailgrid
|
Retailgrid is an AI-powered retail workspace that enables pricing, merchandising, and commercial teams to analyze data, run simulations, and make decisions in real time. Combining a flexible spreadsheet-like interface with AI agents, RetailGrid replaces fragmented tools and manual workflows with a single system for pricing optimization, promotionplanning, and assortment decisions. The platform connects to product, sales, and competitor data, automatically generates insights, and allows teams to test scenarios and deploy decisions at scale. RetailGrid is built for data-driven retailers looking to move faster and operate with the efficiency of top-tier consulting, without the cost or complexity. | $416.2K / Pre-Seed / May 19, 2026 | |
Jaakko.com
|
Reinventing the housing market with no agents, more homes, and less fees. | $584.7K / Seed / Apr 13, 2026 | |
|
Capalo AI
|
Capalo AI offers a state-of-the-art Artificial Intelligence platform for the energy industry. | $13M / Series A / Feb 06, 2026 | |
Cronvall
|
Cronvall is an online B2B marketplace connecting suppliers to business buyers searching profucts for industrial use. | $4.5M / Seed / Nov 13, 2025 | |
SpinDrive
|
Spindrive creates customized levitation technology pushing energy efficiency to the maximum level and promoting oil-free solutions. | Oct 28, 2025 | |
Gesynta Pharma
|
Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se | $4.5M / Series B / Jul 22, 2025 | |
Actithera
|
Actithera is a molecular radiotherapeutic company that develops radioligand therapies. It translates medicinal chemistry insights into new radioligand therapies (RLTs) and applies various molecular design strategies, including covalent targeting and an isotope-agnostic philosophy, to invent RLTs with significant differentiation and largertherapeutic windows. | $75.5M / Series A / Jul 09, 2025 | |
CloEE
|
CloEE is an AI-powered SaaS specifically designed to enhance the productivity and manage quality of end products at discrete manufacturing companies of all sizes. CloEE focuses on real-time data collection from production equipment, reducing emergency stops by up to 95% and improving productivity, reducing reject rates by 2 times and improvingoverall equipment efficiency (OEE) by up to 30%. The CloEE SaaS involves predictive analytics, optimizing operation modes and leading to substantial cost savings on equipment expenses. Drawing on the data collected, CloEE presents the possibilities of generative AI, paving the way for advanced technology management. CloEE team possesses 5+ years of experience working with Industry 4.0 projects and has uplifted 400 large industrial enterprises in 25 countries; over 25,000 machines worldwide are connected and managed with our IT solutions.CloEE aims to reduce carbon emissions by improving OEE and minimizing manufacturing machines worldwide. | $600K / Pre-Seed / Jun 23, 2025 | |
Amplifiles
|
Amplifiles is a PropTech startup that turns real estate listing photos into fully branded, high-quality videos in minute, no filming or editing required. Our video engine helps agents, photographers, and marketplaces boost engagement, generate more leads, and unlock new revenue streams. | Pre-Seed / Apr 01, 2025 | |
| See all 89 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Innovestor invest in?
Innovestor invests primarily in Software, Health Care and Information Technology startups, most often at Seed and Funding Round stage. Most of the 89 investments tracked by Shizune back companies in Finland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Innovestor's check size?
Innovestor typically joins rounds of $478k–$4.5M at Seed and $204k–$2M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Innovestor participates in.
How do I contact Innovestor?
Public channels for Innovestor include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Innovestor?
The team at Innovestor includes Hannu Jungman (Partner, Innovestor Ventures), Janne Juhola (Partner) and Myron Seto (Partner), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
